Model for Lung Repair

​Ground-breaking model for lung repair research and trials

Imperial’s Lung Development and Repair Group has devised a highly effective model to track lung repair to support drug development and academic research.

Their AIR Model (Acid Injury Repair) combines the accessibility of ex-vivo study with the accuracy of working with living tissue.

Using this model, the group can deliver:

  • Bespoke studies of small molecules and growth factors to drive repair
  • Drug testing from pre-clinical models to phase II, first-in-man trials
  • Real-time imaging to track cell behaviour in damaged tissue
  • Consultancy and training to establish the model in client labs and facilities

They can support all levels of biotech and pharmaceutical product development, as well as offering unprecedented depth of observation for academic research.

 

Accuracy of in-vivo research with flexibility of ex-vivo material.

This highly reproducible procedure allows researchers to subject an isolated area of a living lung slice to acid damage, then observe the tissue repair process under a range of conditions.

Unlike traditional organoid-based research, the AIR model preserves the full structure of living tissue – and bridges the historic disconnect between lab work and clinical trials.

It can be run on both animal and human samples at a semi-high throughput scale; and includes a real-time imaging solution, deploying fluorescent tags to enable deep observation at a cellular and sub-cellular level – previously impossible with living tissue.

AIR Model samples also preserve tissue-resident macrophages, offering an indication of immune response that is often unavailable in organoids.

 

Leading Regenerative Medicine Lab

The Lung Development and Repair Group is a multi-disciplinary team of clinicians and researchers with an international reputation, experienced in working with a range of in vivo and ex vivo models across animal and human subjects.

The team can deliver a full development process from pre-clinical models to clinical trials, whilst Dr Sek-Shir Cheong can also consult on its application other settings, including other areas of regenerative medicine.

“The AIR Model has allowed us to work with much greater control at all levels of drug development and research – whether we’re looking to affect signalling pathways, searching for new pro-repair factors or simply following cell behaviour in damaged tissue. We’re excited to apply it in support of clients and partners in industry and wider research fields.” Group Head Dr Charlotte Dean

 

Click here to read more about the team, the AIR model and their work… 

Including: real-time imaging of lung slices

 

Current projects:

And Publication: The acid injury and repair (AIR) model: A novel ex-vivo tool to understand lung repair

Our consultants are world-leading experts in their field, committed to on-going research and innovation, and here to help with your challenges. 

Related Insights

Imperial’s COVID-19 vaccine

Imperial’s COVID-19 vaccine

As the first trials of Imperial’s COVID-19 vaccine candidate got underway in June, the team leading this pioneering work talk though the science of the vaccine and how they will find out whether it protects people from the disease. read more

Digital transformation

Digital transformation

Some think of business as usual, replacing physical tasks with digital alternatives. Others envisage a more profound change, with new products or services made possible by digital technologies. read more

Transport – sector’s response to COVID-19

Transport – sector’s response to COVID-19

As a result of the COVID-19 outbreak, transport providers have to change how they manage their organisations and serve their customers. The Transport Strategy Centre at Imperial have summarised these practices and approaches to help others optimise their responses. read more

Related case studies

Imperial College London Diabetes Centre

Imperial College London Diabetes Centre

The Imperial College London Diabetes Centre was established in Abu Dhabi, in 2006, by Mubadala and experts from Imperial to address the demand for diabetes care in the UAE. With continued support from Imperial, the centre now operates three branches across Abu Dhabi and Al Ain and public health initiatives. read more

Imperial COVID-19 testing facilities

Imperial COVID-19 testing facilities

Imperial's facility, comprising the UKAS accredited Molecular Diagnostic Unit (MDU) and high-throughput robotic platform for RNA extraction, forms part of the Department of Health and Social Care's partnership with the London Testing Alliance, set-up by MedCity. read more

Latest news

Global methane emissions rising at alarming rate

Global methane emissions rising at alarming rate

Our analysis shows that increased human activities are the most likely cause advises Dr Apostolos Voulgarakis. The Global Methane Budget charts the sources and sinks of global methane from our atmosphere. Its 2016 update shows that methane in the atmosphere has increased by 150 percent since the year 1750, and is responsible for 20 percent of the global warming produced by all greenhouse gases so far. read more

Webinar: What will our recovery look like?

Webinar: What will our recovery look like?

23 July 2020 – 12:00 – 13:00 Hear Professor Jonathan Haskel, renowned British economist & Bank of England Monetary Policy committee Member, talk through the economic modelling of the initial recession and the lessons for the recovery. read more

Discovery Channel’s ‘Breaking Magic’

Discovery Channel’s ‘Breaking Magic’

Dr Roberto Trotta provided scientific expertise to the production team of ‘Breaking Magic’, which airs on the Discovery Channel. read more